Shares of Akcea Therapeutics were exploding on Monday after the company revealed that it had signed a licensing agreement with Pfizer for its treatment for people with certain metabolic and cardiovascular diseases. The stock saw a jump as much as 48% on Monday as Wall Street reacted to the news. According to the company’s release, … Continue reading “Akcea Therapeutics Soars on Licensing Agreement with Pfizer”
